Predictive value of the combination of serum markers, CAI 25, CASA and TPS in ovarian cancer

This publication has 14 references indexed in Scilit:

• CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery
  European Journal Of Cancer, 1993
• CA 125 in gynecological pathology — a review
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
• The management of ovarian carcinoma is improved by the use of cancer-associated serum antigen and CA 125 assays
  Cancer, 1993
• Preoperative discrimination between ovarian carcinoma, non-ovarian gynecological malignancy and benign adnexal masses using serum levels of CA125 and the polymorphic epithelial mucin antigens CASA, OSA and MSA
  International Journal of Gynecologic Cancer, 1992
• Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma—Comparison with CA125
  Gynecologic Oncology, 1990
• Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: Relevance for early detection of ovarian cancer
  International Journal of Cancer, 1988
• Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease
  American Journal of Obstetrics and Gynecology, 1988
• An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma
  Gynecologic Oncology, 1988
• Preoperative Serum CA-125 Levels in Patients With Surgical Stage I Invasive Ovarian Adenocarcinoma
  JNCI Journal of the National Cancer Institute, 1988
• Basic principles of ROC analysis
  Seminars in Nuclear Medicine, 1978